c.boateng

TL2 · Kaunas

Contributes reviews on supplier material. Based in Kaunas.

Joined 8 December 2024 · last posted 2d

85 posts, newest first. Showing up to 150.

I joined for one answer and stayed for a year — what changed my mind Replied, post #111 · Start Here › Welcome · 26 Jul 2026 · 28 likes Bookmarking this. I will come back when I have something worth adding.
Why the Start Here categories exist, and what they are not for Replied, post #41 · Start Here › Welcome · 26 Jul 2026 · 0 likes Since Start keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct experience will…
What to bring: records that a clinician can actually use — a second dataset Replied, post #50 · Clinical › Prescriber conversations · 18 Jul 2026 · 0 likes Quietly grateful for the plain phrasing. Not every thread gets that.
What is genuinely unknown about long-term amylin agonism Replied, post #49 · Compounds › Cagrilintide & amylin analogues · 17 Jul 2026 · 11 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
Restarting after a long gap: what the labelling implies Replied, post #30 · Practice › Dosing & titration · 17 Jul 2026 · 0 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.…
Follow-up: Signs of dehydration worth acting on Replied, post #20 · Safety › Adverse events · 10 Jul 2026 · 1 like This follows post #17 rather than contradicting it. Reporting here and reporting to a national scheme are not alternatives. The second is what feeds safety…
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #42 · Compounds › Retatrutide · 6 Jul 2026 · 24 likes Post #41 put the caveat in the right place and I want to underline it. I would keep retatrutide discussion and the decision it usually gets used for separate in this…
[2026 update] Temperature indicator cards: worth asking for? Replied, post #14 · Sourcing › Logistics · 2 Jul 2026 · 3 likes Noted, and I have changed what I was going to do on the strength of it.
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #104 · Evidence › Journal club · 27 Jun 2026 · 31 likes I changed my mind about orforglipron phase 2 after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the…
Submitting a sample: the process end to end Replied, post #41 · Sourcing › Independent verification · 27 Jun 2026 · 15 likes Adding the measurement that post #38 says would settle it. Answering the submitting a sample question as asked, then the question I think is meant. As asked: yes, with…
A critique that turned out to be unfair, retracted by its author Replied, post #19 · Evidence › Study critique · 26 Jun 2026 · 22 likes A critique should end with what would change your mind. Without that it is a position rather than an argument. The number is defensible. The precision I gave it is not.
Ultrasound and skinfolds: operator dependence in practice Replied, post #29 · Outcomes › Body composition · 24 Jun 2026 · 0 likes Where I would push back on the ultrasound and skinfolds consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
About the Syringes & needles category Replied, post #5 · Devices › Syringes & needles · 20 Jun 2026 · 6 likes Silicone coating on the barrel affects how smoothly the plunger moves and how a very slow injection feels. It is one reason two syringes at the same specification are…
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #8 · Analytics › Impurities & related substances · 12 Jun 2026 · 19 likes Off-target structures: if the sequence synthesis goes wrong, a completely different amino acid can be incorporated. The resulting off-target peptide is a structural…
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #131 · Practice › Storage & stability · 9 Jun 2026 · 0 likes I read post #130 twice before replying, because I had assumed the opposite. The bit of Storing lyophilised material long term that nobody enjoys is that the answer…
Prescription requirements and telehealth models — a second dataset Replied, post #52 · Sourcing › Regulatory · 3 Jun 2026 · 0 likes Adding the measurement that post #51 says would settle it. Nothing in this subcategory is legal advice, and the members who work in regulated environments are the most…
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #55 · Practice › Storage & stability · 3 Jun 2026 · 0 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. A qualification I…
Coming back to: Storing in the door of the fridge is worse than you think Replied, post #3 · Practice › Storage & stability · 20 May 2026 · 5 likes Post #2 answers the question as asked. The question underneath it is different. Light protection is easy and cheap. The original carton exists for a reason and a vial…
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #19 · Compounds › Retatrutide · 30 Apr 2026 · 25 likes Post #15 describes the usual case. This is about the unusual one. Since TRIUMPH keeps coming up, it should probably be a maintained page rather than a recurring thread.…
Journal club: SURMOUNT-4 and continuation versus withdrawal Replied, post #36 · Evidence › Journal club · 23 Apr 2026 · 7 likes Post #32 and I disagree about the size of the effect, not about the direction. SURMOUNT-4 and continuation versus withdrawal is a good example of a question where the…
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #31 · Devices › Syringes & needles · 14 Apr 2026 · 7 likes Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible for small doses. Larger barrels hold larger volumes. Choose based on…
The "under review" status pill and when a moderator applies it Replied, post #66 · Evidence › Preprints · 10 Apr 2026 · 6 likes Post #64 and I disagree about the size of the effect, not about the direction. Sample size and pre-registration are checkable in a preprint exactly as in a paper, and…
Travelling with an injectable: documentation and practicalities Replied, post #20 · Access › International · 9 Apr 2026 · 1 like Adding thanks rather than a view. I do not have a view worth the space.
Conditions that change the calculus rather than forbidding it Replied, post #7 · Safety › Contraindications · 6 Apr 2026 · 2 likes Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the same compound or to structurally similar peptides warrants…
Validating a method you did not develop Replied, post #13 · Analytics › Method validation · 31 Mar 2026 · 0 likes That reframing is the whole thing. The facts I already had.
Anaesthesia and elective surgery: the aspiration question Replied, post #64 · Practice › Interactions · 27 Mar 2026 · 0 likes Coming back to post #60, because the follow-up matters more than the original answer. A methods point on anaesthesia and elective surgery rather than a substantive one:…
Stepping down deliberately, and how to do it without losing progress Replied, post #79 · Practice › Dosing & titration · 23 Mar 2026 · 5 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.…
Choosing which test to pay for, given a fixed budget Replied, post #35 · Sourcing › Independent verification · 22 Mar 2026 · 10 likes A record with four results over sixteen months is a thin record rather than a bad one, and the honest description says which. Written quickly, so the reasoning may be…
Managing an unplanned gap in supply Replied, post #68 · Access › Shortages · 21 Mar 2026 · 15 likes Nothing here is medical advice, and decisions about what to do during a supply interruption belong with a prescriber.
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #50 · Compounds › Repair & healing peptides · 13 Mar 2026 · 9 likes I came in to disagree and I am leaving without a disagreement.
The headache that turns out to be dehydration — the long version Replied, post #7 · Nutrition & Training › Hydration & electrolytes · 7 Mar 2026 · 9 likes A request rather than an answer: could whoever has the primary source for headache post it? I have seen the claim three times this month and each version had lost a…
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #39 · Pharmacology › Pharmacokinetics · 11 Feb 2026 · 16 likes I read post #35 twice before replying, because I had assumed the opposite. Where two sources give different half-lives, check the study design before deciding either is…
Adsorption to container surfaces and to plastics Replied, post #12 · Pharmacology › Formulation chemistry · 29 Jan 2026 · 0 likes A note on how adsorption gets discussed rather than on adsorption itself: the confident posts get the replies and the careful ones get ignored, and the careful ones…
The headache that turns out to be dehydration Replied, post #157 · Nutrition & Training › Hydration & electrolytes · 27 Jan 2026 · 12 likes I had written a reply contradicting post #153 and deleted it. Here is what survived. The most useful thing anyone has posted about headache in this category was a table…
Preprint servers and what screening they do Replied, post #36 · Evidence › Preprints · 27 Jan 2026 · 0 likes Post #32 describes the usual case. This is about the unusual one. Check whether it was later published: searching for the preprint's first author and keywords in PubMed…
Second pass at: The topic list is dense — is that deliberate? Replied, post #32 · Meta › Site feedback · 31 Dec 2025 · 1 like On post #30 — agreed on the reasoning, with one qualification. Summarising the topic list thread so far, since it is long and the answer is buried: the first reply has…
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #116 · Compounds › Oral incretins · 28 Dec 2025 · 11 likes Post #114 is right about the mechanism and I think understates the practical bit. The absorption enhancer in the licensed oral product works by transiently raising…
Reading SURMOUNT-1 without the press release Replied, post #115 · Compounds › Tirzepatide · 26 Dec 2025 · 0 likes The arithmetic in post #112 is right; the assumption feeding it is the part to check. Checked the reading SURMOUNT-1 without the press claim against the primary source…
The decimal-point error, and the habit that catches it Replied, post #8 · Practice › Reconstitution · 13 Dec 2025 · 3 likes Post #5 answers the question as asked. The question underneath it is different. Preservative effectiveness is tested against a defined microbial challenge under defined…
Publishing an inconvenient result: a case study — the long version Replied, post #55 · Sourcing › Independent verification · 1 Dec 2025 · 8 likes The failure mode on Publishing an inconvenient result is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too…
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #18 · Clinical › Bloodwork · 27 Nov 2025 · 24 likes Adding a data point of agreement rather than a data point.
Hair shedding at month three: mechanism and time course Replied, post #2 · Practice › Side effects · 23 Nov 2025 · 0 likes Delayed gastric emptying: the mechanism behind much of the gastrointestinal side-effect profile. At extreme magnitudes, severe gastroparesis is a rare but serious…
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Replied, post #40 · Sourcing › Regulatory · 20 Nov 2025 · 0 likes Worth separating Pharmaceutical compounding rules as a question about the compound from Pharmaceutical compounding rules as a question about the documentation. They get…
Where to report an adverse event officially, by region — a second dataset Replied, post #101 · Safety › Adverse events · 7 Nov 2025 · 1 like Nothing here is medical advice, and in this subcategory the phrase is doing more work than in any other on the site.
High-resolution MS on aggregates and what it can see Replied, post #105 · Analytics › Mass spectrometry · 28 Oct 2025 · 30 likes Deamidation adds approximately one dalton and produces a species that frequently elutes very close to the parent. It is the hardest common impurity to see…
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #18 · Compounds › Tirzepatide · 19 Oct 2025 · 20 likes A note on how SURMOUNT-4 gets discussed rather than on SURMOUNT-4 itself: the confident posts get the replies and the careful ones get ignored, and the careful ones…
Power cut for eleven hours: how I assessed it afterwards Replied, post #97 · Practice › Storage & stability · 15 Oct 2025 · 30 likes On post #93 — agreed on the reasoning, with one qualification. An observation about power cut for eleven hours that I cannot explain and am posting anyway, on the…
A parcel that arrived warm: a decision process, not a verdict Replied, post #64 · Practice › Storage & stability · 2 Oct 2025 · 11 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear.
Hypertension improvement and when medication needs revisiting Replied, post #74 · Clinical › Comorbidities · 21 Sep 2025 · 2 likes No disagreement from me. Posting only so the question does not look ignored.
Which panel is worth repeating and which is worth ignoring Replied, post #94 · Clinical › Bloodwork · 26 Aug 2025 · 0 likes Nothing in this subcategory is medical advice, and a panel with an unexpected result is precisely the situation where that matters.
What a documentation review can and cannot tell you Replied, post #68 · Sourcing › Independent verification · 10 Aug 2025 · 17 likes Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is…
When a preprint is the best available evidence and we say so Replied, post #37 · Evidence › Preprints · 9 Aug 2025 · 0 likes Post #36 describes the usual case. This is about the unusual one. Reading this preprint thread as someone who came in with a fixed view: the third and seventh replies…
Travel coolers and how long they really hold Replied, post #44 · Devices › Cold chain · 4 Aug 2025 · 32 likes Where I part company with post #40, and it is a narrow parting. Where I have landed on travel coolers, having got it wrong once in public: the direction is clear, the…
Reporting a disappointing outcome, and why it belongs here Replied, post #21 · Outcomes › Progress reports · 20 Jul 2025 · 20 likes Where I part company with post #17, and it is a narrow parting. If someone has run reporting a disappointing outcome properly I would rather read that than my own…
Coming back to: Official shortage notices and what they authorise Replied, post #58 · Access › Shortages · 15 Jul 2025 · 14 likes Coming back to post #56, because the follow-up matters more than the original answer. Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose…
BPC-157: what the rodent literature actually shows, and what it does not Replied, post #19 · Compounds › Repair & healing peptides · 15 Jul 2025 · 30 likes Confirming post #16 from a second method, which matters more than confirming it from a second person. The preclinical work is genuinely interesting and it is…
Persistent vomiting and the threshold for seeking help Replied, post #2 · Safety › Adverse events · 2 Jul 2025 · 1 like Worth separating two things that the opening post runs together. Two people in this thread mean different things by persistent vomiting and are disagreeing about the…
Second pass at: Designing a personal experiment that could change your mind Replied, post #35 · Research Methods › N-of-1 designs · 21 May 2025 · 23 likes Sensible. I would want the same detail before I acted on it either.
Coverage for the indication versus for the drug Replied, post #74 · Access › Insurance & coverage · 21 May 2025 · 15 likes Same experience here, different supplier, so it is at least not unique to one of them.
Validating a calculator against hand arithmetic — what changed since Replied, post #81 · Data & Tools › Calculators · 21 May 2025 · 25 likes Maintaining a calculator means checking the arithmetic against hand-worked cases at each review, not checking that it still loads.
DXA precision and the least significant change for lean mass — the long version Replied, post #58 · Outcomes › Body composition · 18 May 2025 · 11 likes Preserving lean tissue during a substantial deficit depends on protein intake and a resistance stimulus, and the evidence for both is reasonably strong.
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #106 · Practice › Reconstitution · 14 May 2025 · 15 likes Reconstituting the whole vial when you will use a quarter of it is a decision to store the rest in solution, which is the least stable state it will ever be in.…
Validating a calculator against hand arithmetic — what changed since Replied, post #62 · Data & Tools › Calculators · 11 May 2025 · 0 likes Coming back to post #60, because the follow-up matters more than the original answer. Two people in this thread mean different things by Validating a calculator against…
Fibre intake when total intake falls, and the constipation link Replied, post #59 · Nutrition & Training › Protein & intake · 26 Apr 2025 · 1 like Micronutrient adequacy becomes a real question at very low total intake and is much less discussed than protein. The disagreement above is smaller than it looks once…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #77 · Evidence › Journal club · 20 Apr 2025 · 20 likes What I would want before treating STEP 1 as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three are usually missing.
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #29 · Compounds › Repair & healing peptides · 31 Mar 2025 · 0 likes The arithmetic in post #27 is right; the assumption feeding it is the part to check. BPC-157's published evidence is overwhelmingly preclinical and mostly rodent. That…
Deamidation and the close-eluting pair it produces Replied, post #15 · Analytics › Impurities & related substances · 27 Mar 2025 · 19 likes Building on post #14 rather than restating it. A methods point on deamidation rather than a substantive one: if the comparison is not like for like, the difference you…
Counter-ion form: the field almost nobody reports — one year on Replied, post #3 · Analytics › COA interpretation · 15 Feb 2025 · 14 likes Post #2 is right about the mechanism and I think understates the practical bit. Counter-ion form is well covered in the tag pages, and the older discussions are better…
Distinguishing a deletion sequence by mass alone Replied, post #85 · Analytics › Mass spectrometry · 14 Feb 2025 · 0 likes Reading back through, this was answered upthread and I missed it. My fault.
A ten-fold dose error caught before injection Started this topic · Devices › Syringes & needles · 12 Feb 2025 · 20 likes A ten-fold dose error caught before injection — setting out what I have, and where I think it stops being reliable. Trying to work out what would count as evidence on…
Revisiting: Aggregate verification data across the directory, with caveats Replied, post #5 · Sourcing › Independent verification · 10 Feb 2025 · 10 likes Where I part company with post #3, and it is a narrow parting. A record with four results over sixteen months is a thin record rather than a bad one, and the honest…
Follow-up: Individual participant data versus aggregate data Replied, post #101 · Evidence › Meta-analyses · 11 Jan 2025 · 0 likes Pooled estimates and heterogeneity: when trials differ in population, duration, or comparator, a pooled estimate answers a question that no individual trial asked. High…
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #26 · Compounds › Oral incretins · 6 Jan 2025 · 0 likes The gastrointestinal tolerability profile of the oral formulation is broadly similar in character to the injectable, which supports the effects being systemic rather…
Why we hide unevidenced fraud accusations and log the hiding Replied, post #34 · Sourcing › Red flags · 3 Jan 2025 · 1 like The most useful contribution to this subcategory is a resolved case written up with the resolution, because the unresolved ones are all anyone remembers. That is one…
Coming back to: Why the cheapest option is often not the cheapest Replied, post #6 · Access › Pricing · 27 Dec 2024 · 25 likes The cost of an independent submission is worth stating in these threads, because it is the main reason people do not do it.
Building a sensible monitoring schedule with your prescriber Replied, post #36 · Clinical › Bloodwork · 19 Dec 2024 · 25 likes Coming back to post #32, because the follow-up matters more than the original answer. I disagree with the framing of building a sensible monitoring schedule above, and…
UK access routes, dated and sourced — a second dataset Replied, post #11 · Regional › UK & Ireland · 29 Nov 2024 · 6 likes Importing for personal use: importing a prescription-only medicine without a prescription is not lawful. Material sold as research-use-only is not a licensed medicine…
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #6 · Evidence › Journal club · 24 Nov 2024 · 15 likes Confirming post #3 from a second method, which matters more than confirming it from a second person. I keep a log for SUSTAIN 6 specifically because my memory of it…
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #53 · Clinical › Special populations · 24 Nov 2024 · 0 likes Nothing in this subcategory is medical advice and the questions asked here are precisely the ones that need an individual assessment.
Why "any advice?" is the least effective ending for a post Replied, post #58 · Start Here › How to Ask · 21 Nov 2024 · 0 likes Right — I had this wrong and I am glad to have read it before it mattered.
[2026 update] New subcategory: rationale and scope Replied, post #15 · Meta › Announcements · 21 Nov 2024 · 0 likes Marking my place. If it changes for me I will come back and say so.
Research-use-only labelling: what it means and what it does not — the long version Replied, post #25 · Sourcing › Regulatory · 11 Nov 2024 · 13 likes The arithmetic in post #22 is right; the assumption feeding it is the part to check. Research-use-only labelling came up in a thread eighteen months ago and was…
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #50 · Clinical › Bloodwork · 23 Sep 2024 · 16 likes Post #49 is right about the mechanism and I think understates the practical bit. The useful distinction on bring a laboratory is between what was measured and what was…
Identical chromatograms across two different lots Replied, post #23 · Sourcing › Red flags · 8 Sep 2024 · 5 likes Summarising the identical chromatograms thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it,…
Progressive overload when the scale is falling — one year on Replied, post #10 · Nutrition & Training › Resistance training · 28 Aug 2024 · 1 like The claim about Progressive overload upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says "causes".